AUG 07, 2020 7:36 AM PDT

Using organoids to improve chemotherapy for advanced stages of colon and appendiceal cancer

New research published in the journal Annals of Surgical Oncology uses organoids to finetune chemotherapies that treat patients with advanced stages of colon and appendiceal cancer. Organoids are 3D multicellular in vitro tissue formed from pluripotent stem cells or adult progenitor cells that mimic their corresponding in vivo organ. They provide an alternative to studying drug development using traditional 2D cell cultures and animal models, which have certain limitations.

The specific organoids used for this research were made by researchers at the Wake Forest Organoid Research Center (WFORCE) who wanted to determine a method of improving hyperthermic intraperitoneal chemotherapy (HIPEC), the therapy that is administered to cancer patients who have tumors in their abdomens. HIPEC has been shown to increase life expectancy for patients when combined with cytoreductive surgery to remove tumors in the abdomen.

Using patient-specific tumor organoid models, the researchers showed how it is possible to predict the effectiveness of HIPEC on certain individuals and henceforth personalize a patient-specific approach.

"With this organoid platform, we can quantify the impact of each drug in killing cancer cells. We can select the correct drug for the correct patient at the correct concentration and temperature, or even spare the patient from a procedure that will not substantially improve his or her outcomes," explained senior author Konstantinos Votanopoulos, MD, Ph.D., professor of surgery.

"Using a patient-specific tumor organoid model will eventually allow patients to be treated with the best available chemotherapy while sparing the toxicity of drugs that are not effective for their specific tumor," added first author Steven Forsythe, MS.

Photo: Pixabay

Co-author Shay Soker, PhD is a professor of regenerative medicine at WFIRM. Soker says that these findings demonstrate that "the organoid model can accurately represent what occurs inside a patient's body.” By simulating the environment inside of organs, organoids offer a unique opportunity. “The research continues to show that organoids are promising candidates for drug screening to assist in clinical decision making as well as in the study of how environmental factors, viruses or toxins impact cellular function of both normal and tumor cells," concludes Soker.

Sources: Annals of Surgical Oncology, Eureka Alert 

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 12, 2020
Immunology
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
NOV 12, 2020
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
Nutrition is essential to health; what we eat in our daily diet affects our overall health condition and what diseases w ...
NOV 19, 2020
Cancer
New technique to synthesize phenazines offers hope for cancer treatments
NOV 19, 2020
New technique to synthesize phenazines offers hope for cancer treatments
Research from Tokyo University of Science investigators highlights new accomplishments in the fight against cancer. The ...
DEC 21, 2020
Cancer
Examining the Bioactive Components of an Alga Against Cancer
DEC 21, 2020
Examining the Bioactive Components of an Alga Against Cancer
Many of today’s drugs come from vast libraries of synthetic compounds built by chemists for big pharma. This drug ...
JAN 06, 2021
Immunology
What's Causing Prostate Cancer Patients to Doze Off?
JAN 06, 2021
What's Causing Prostate Cancer Patients to Doze Off?
For prostate cancer patients, androgen deprivation therapy or ADT is a standard treatment aimed at stalling the growth o ...
JAN 12, 2021
Clinical & Molecular DX
Portable Sequencer Ensures All the Cancer Cells Are Gone
JAN 12, 2021
Portable Sequencer Ensures All the Cancer Cells Are Gone
Surgeons remove a tumor from the abdominal cavity of a patient. But how can they be certain that all the cancer cells we ...
JAN 21, 2021
Cancer
Whole body MRI shown to be most sensitive in detecting myeloma
JAN 21, 2021
Whole body MRI shown to be most sensitive in detecting myeloma
New research suggests that whole body magnetic resonance imaging (WBMRI) is a more effective detection method than other ...
Loading Comments...